A Phase III, Multicenter, Double Blind, Randomized Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL
Latest Information Update: 29 Nov 2023
Price :
$35 *
At a glance
- Drugs Yellow fever vaccine-Serum Institute of India (Primary)
- Indications Yellow fever
- Focus Pharmacodynamics; Registrational
- Sponsors Serum Institute of India
- 21 Nov 2023 Upper age limit for the inclusion criteria is increased from 60 to 99 years, thus including elderly patients also.
- 21 Nov 2023 Planned number of patients changed from 2280 to 1824.
- 21 Nov 2023 Planned End Date changed from 30 Jun 2024 to 10 May 2024.